A twelve-month comparative clinical investigation of two low-dose oral contraceptives containing 20 μg ethinylestradiol/75 μg gestodene and 30 μg ethinylestradiol/75 μg gestodene, with respect to efficacy, cycle control, and tolerance
- 31 March 1997
- journal article
- clinical trial
- Published by Elsevier in Contraception
- Vol. 55 (3), 131-137
- https://doi.org/10.1016/s0010-7824(97)00025-5
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- A three-year clinical investigation into efficacy, cycle control and tolerability of a new low-dose monophasic oral contraceptive containing gestodeneGynecological Endocrinology, 1996
- A twelve-month comparative clinical investigation of two low-dose oral contraceptives containing 20 μg ethinylestradiol/75 μg gestodene and 20 μg ethinylestradiol/150 μg desogestrel, with respect to efficacy, cycle control and toleranceContraception, 1995
- Clinical comparison of monophasic oral contraceptive preparations of gestodene/ ethinyl estradiol and desogestrel/ethinyl estradiolContraception, 1994
- A comparison of the effects of two monophasic low dose oral contraceptives on the inhibition of ovulationAdvances in Contraception, 1994
- New progestogens in oral contraceptionContraception, 1994
- Comparative profiles of reliability, cycle control and side effects of two oral contraceptive formulations containing 150 μg desogestrel and either 30 μg or 20 μg ethinyl oestradiolBJOG: An International Journal of Obstetrics and Gynaecology, 1993
- Oral Contraceptive Estrogen Dose and the Risk of Deep Venous Thromboembolic DiseaseAmerican Journal of Epidemiology, 1991